IMMUNYX

immunyx-logo

Immunyx is a drug development company that produces and markets complete therapeutic products for neutrophils and immune cells.

#Website #More

IMMUNYX

Social Links:

Industry:
Health Care Health Diagnostics Medical

Founded:
2021-01-01

Address:
Jerusalem, Yerushalayim, Israel

Country:
Israel

Website Url:
http://www.immunyx.com

Total Employee:
1+

Status:
Active

Technology used in webpage:
SPF Euro Google Apps For Business GoDaddy DNS GoDaddy


Official Site Inspections

http://www.immunyx.com Semrush global rank: 9.54 M Semrush visits lastest month: 141

  • Host name: 113.0.153.160.host.secureserver.net
  • IP address: 160.153.0.113
  • Location: Scottsdale United States
  • Latitude: 33.6013
  • Longitude: -111.8867
  • Metro Code: 753
  • Timezone: America/Phoenix
  • Postal: 85260

Loading ...

More informations about "Immunyx"

ImmunyX - A New Paradigm for Immune Modulation

Immunyx is a drug development company focused on neutrophil modulation in disease. Our Technology. The Challenge: Neutrophil Therapy. Neutrophils are the most populous immune cell, yet few advances have been made in modulating โ€ฆSee details»

About Us - A New Paradigm for Immune Modulation

Immunyx strives to improve disease treatment. If youโ€™re interested in our mission we would love to hear from you. Name Email Message Send Message. 210 W. 90th Street New York NY โ€ฆSee details»

Immunyx - Crunchbase Company Profile & Funding

Organization. Immunyx . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. ... Immunyx is located in โ€ฆSee details»

Immunyx Pharma - Israeli Startup | Startup Nation Finder

Immunyx Pharma is a drug development company focused on modulating neutrophil function to treat disease. Using the company's platform technology to specifically manipulate neutrophils โ€ฆSee details»

Immunyx Pharma - PitchBook

Immunyx Pharma General Information Description. Operator of a drug development company intended to modulate neutrophil function to treat diseases. The company offers pioneering โ€ฆSee details»

Immunyx - VLX Ventures

Immunyx is a drug development company focused on modulating neutrophil function to treat disease. Numerous high burden illnesses such as COPD, cancer, and arthritis involve โ€ฆSee details»

Immunyx Pharma - VentureRadar

Immunyx is pioneering new approaches to immune modulation using targeted nanoparticles to change the function of neutrophils. Our team of world experts in neutrophil biology and โ€ฆSee details»

Technology - A New Paradigm for Immune Modulation

Immunyx strives to improve disease treatment. If youโ€™re interested in our mission we would love to hear from you. Name Email Message Send Message. 210 W. 90th Street New York NY 10024; We generated a neutrophil targeting, โ€ฆSee details»

Immunyx - Company Profile - Tracxn

Feb 26, 2025 Immunyx - Developer of neutrophil therapies for multiple diseases. Raised funding over 1 round from 2 investors. Founded by Zvi Fridlender, Zvika Granot and 1 other in the year โ€ฆSee details»

Immunyx Pharma - Overview, News & Similar companies - ZoomInfo

Immunyx Pharma is focused on changing the landscape of immune modulation by targeting neutrophil toxicity in numerous chronic diseases. The company was built by world leaders in โ€ฆSee details»

Immunyx | Funding & Investors - Tracxn

List of Funding Rounds and Investors of Immunyx. List of Funding Rounds and Investors of Immunyx Toggle navigation. Solutions. By Investment Industry. Venture Capital Funds Private โ€ฆSee details»

Zvika Granot: Positions, Relations and Network - MarketScreener

Founder at Immunyx Pharma Ltd., Discover Zvika Granot's known position history, network and 3 relationships. Find out about his known public assets.See details»

Top Respiratory start-ups - VentureRadar

Immunyx Pharma. Privately Held. Founded 2021. Israel. Immunyx is pioneering new approaches to immune modulation using targeted nanoparticles to change the function of neutrophils. Our โ€ฆSee details»

Our Pipeline - A New Paradigm for Immune Modulation

Immunyx strives to improve disease treatment. If youโ€™re interested in our mission we would love to hear from you. Name Email Message Send Message. 210 W. 90th Street New York NY โ€ฆSee details»

Immunofyx

ImmunoFyx is developing novel immuno-therapeutics to reduce the growth, angiogenesis, and metastasis of solid tumors. We specifically target and inhibit a highly expressed cell surface โ€ฆSee details»

MemoryPlus - Israeli Startup | Startup Nation Finder

Jan 1, 2025 Work Email* (please provide your email in the organization) Position* Notes. Send Create Free Account. Create Free Account. 8 Characters, Uppercase letter (A-Z), Lowercase โ€ฆSee details»

PARTICIPATING COMPANIES

Biotech Showcase attracts a wide range of business leaders, including senior executives of leading biotech companies, business development teams from large and midsize โ€ฆSee details»

Management of the 2022 Mpox (Monkeypox) Outbreak in Canada

Mar 7, 2025 On November 28, 2022, the World Health Organization recommended the new preferred term "mpox" over the previous terminology "monkeypox" to refer to the disease โ€ฆSee details»

Partnerships - A New Paradigm for Immune Modulation

Immunyx strives to improve disease treatment. If youโ€™re interested in our mission we would love to hear from you. Name Email Message Send Message. 210 W. 90th Street New York NY โ€ฆSee details»

ImmUnity Canada - Primary Immunodeficiency Society

Formerly the Canadian Immunodeficiencies Patient Organization. Empowering people with primary immunodeficiency to live well. Learn More. Newly diagnosed? Start here. Find support โ€ฆSee details»